Prospeo
Hero Section BackgroundHero Section Background
Neurocrine Biosciences

Neurocrine Biosciences Revenue

Biotechnology Research6027 Edgewood Bend Ct, San Diego, United States2001-5000 Employees

$

Neurocrine Biosciences revenue & valuation

Annual revenue$2,509,900,000
Revenue per employee$1,246,000
Estimated valuation?$8,031,700,000
Total fundingNo funding

Company overview

Headquarters6027 Edgewood Bend Ct, San Diego, California 92130, US
Phone number+18586177600
Website
NAICS541714
SIC283
Keywords
Neurology, Endocrinology, Immunology, CNS, Movement Disorders
Founded1992
Employees2001-5000
Socials

Neurocrine Biosciences Email Formats

Neurocrine Biosciences uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@neurocrine.com), used 61.1% of the time.

FormatExamplePercentage
{first name}{last name}
johndoe@neurocrine.com
61.1%
{first initial}{last name}
jdoe@neurocrine.com
33.4%
{last name}{last name}
doedoe@neurocrine.com
4.4%

About Neurocrine Biosciences

Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines *in collaboration with AbbVie

Employees by Management Level

Total employees: 2001-5000

Seniority

Employees

Entry
Manager
Senior

Employees by Department

Neurocrine Biosciences has 846 employees across 18 departments.

Departments

Number of employees

Funding Data

Neurocrine Biosciences has never raised funding before.

Neurocrine Biosciences Tech Stack

Discover the technologies and tools that power Neurocrine Biosciences's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

reCAPTCHA

Security

Slick

Slick

JavaScript libraries

Vimeo

Vimeo

Video players

jQuery Migrate

jQuery Migrate

JavaScript libraries

Yoast SEO Premium

Yoast SEO Premium

SEO

jQuery

jQuery

JavaScript libraries

Apple iCloud Mail

Apple iCloud Mail

Webmail

PHP

PHP

Programming languages

HSTS

HSTS

Security

WP-PageNavi

WP-PageNavi

WordPress plugins

WordPress

WordPress

Blogs

Google Analytics

Google Analytics

Analytics

Frequently asked questions

Neurocrine Biosciences is located in 6027 Edgewood Bend Ct, San Diego, US.
You can reach Neurocrine Biosciences at +18586177600.
Neurocrine Biosciences generates an estimated annual revenue of $2,509,900,000. This revenue figure reflects the company's market position and business performance in its industry.
Neurocrine Biosciences has an estimated valuation of $8,031,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Neurocrine Biosciences was founded in 1992, making it 34 years old. The company has established itself as a significant player in its industry over this time.
Neurocrine Biosciences has approximately 2001-5000 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Neurocrine Biosciences

Kyle W. Gano

Chief Executive Officer

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles

Neurocrine Biosciences Revenue, Funding & Valuation